Begoña Mellado

Publicaciones destacadas

• Safety and efficacy of avelumab plus carboplatin in patients with metastatic castration-resistant prostate cancer in an open-label Phase Ib study

  Autores:

  Rodriguez-Vida, Alejo; Maroto, Pablo; Font, Albert; Martin, Cristina; Mellado, Begona;

  (...)

  Taus, Alvaro; Martinez-Garcia, Maria; Juanpere, Nuria; Juan, Oscar; Bellmunt, Joaquim.

  Ver listado completo de autores

  Referencia: British Journal Of Cancer 2023.

• A phase II randomised trial of abiraterone acetate plus prednisone in combination with docetaxel or docetaxel plus prednisone after disease progression to abiraterone acetate plus prednisone in patients with metastatic castration-resistant prostate cancer: The ABIDO-SOGUG trial

  Autores:

  Climent, Miguel A; Climent, Miguel A; Font, Albert; Duran, Ignacio; Puente, Javier;

  (...)

  Lazaro-Quintela, Martin; Cassinello-Espinosa, Javier; Perez-Valderrama, Begona; Garcias, Carmen; Castellano, Daniel.

  Ver listado completo de autores

  Referencia: European Journal Of Cancer 2022.

• Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer: The VIABLE Phase 3 Randomized Clinical Trial

  Autores:

  Nicholas J. Vogelzang; Tomasz M. Beer; Winald R. Gerritsen; Stéphane Oudard; Paweł Wiechno;

  (...)

  William D. Walsh; Bernard J. Poiesz; Lauren C. Harshman; Nancy A. Dawson; Sanjay Sharma.

  Ver listado completo de autores

  Referencia: Jama Oncology 2022.

• Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial

  Autores:

  Matthew R. Smith; Howard I. Scher; Shahneen Sandhu; Eleni Efstathiou; Primo N. Lara;

  (...)

  Hamid Emamekhoo; Jacek Pinski; Arash Rezazadeh Kalebasty; Joseph Maly; Helen Moon.

  Ver listado completo de autores

  Referencia: Lancet Oncology 2022.

• Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma

  Autores:

  Motzer, Robert J; Powles, Thomas; Atkins, Michael B; Escudier, Bernard; McDermott, David F;

  (...)

  Craine, Veronica; Huseni, Mahrukh; Flinn, Nick; Dubey, Sarita; Rini, Brian, I.

  Ver listado completo de autores

  Referencia: Jama Oncology 2022.

• Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study

  Autores:

  Siefker-Radtke AO; Necchi A; Park SH; García-Donas J; Huddart RA;

  (...)

  Santiago-Walker AE; Monga M; O'Hagan A; Loriot Y; BLC2001 Study Group.

  Ver listado completo de autores

  Referencia: Lancet Oncology 2022.

• Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial

  Autores:

  Powles, T; Yuen, KC; Kadel, EE; Doss, JF; Mariathasan, S;

  (...)

  Mellado, B; Karaszewska, B; Rasuo, G; Datye, A; Sweeney, CJ.

  Ver listado completo de autores

  Referencia: Nature Medicine 2022.

• Glutamine and cholesterol plasma levels and clinical outcomes of patients with metastatic castration-resistant prostate cancer treated with taxanes

  Autores:

  Marin-Aguilera, Mercedes; Pereira, Maria V; Jimenez, Natalia; Reig, Oscar; Cuartero, Anna;

  Victoria, Ivan; Aversa, Caterina; Ferrer-Mileo, Laura; Prat, Aleix; Mellado, Begona.

  Referencia: Cancers 2021.

• Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment

  Autores:

  de Porras, VR; Solé-Blanch, C; Bystrup, S; Martinez-Balibrea, E; Pardo, JC;

  (...)

  Conteduca, V; Beltran, H; Buisan, O; Castro, E; Olmos, D.

  Ver listado completo de autores

  Referencia: European Urology 2021.

• Androgen Receptor and Its Splicing Variant 7 Expression in Peripheral Blood Mononuclear Cells and in Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer

  Autores:

  Marin-Aguilera, Mercedes; Jimenez, Natalia; Reig, Oscar; Montalbo, Ruth; Verma, Ajit K;

  (...)

  Cabezon, Raquel; Gonzalez, Azucena; Juan, Manel; Prat, Aleix; Mellado, Begona.

  Ver listado completo de autores

  Referencia: Cells 2020.